CHIR-98014

TargetMol
Product Code: TAR-T2608
Supplier: TargetMol
CodeSizePrice
TAR-T2608-5mg5mg£125.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2608-1mL1 mL * 10 mM (in DMSO)£129.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2608-10mg10mg£158.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2608-25mg25mg£254.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2608-50mg50mg£369.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2608-100mg100mg£550.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2608-500mg500mg£1,083.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
CHIR-98014 is a selective GSK3 inhibitor; potentiate insulin activation of glucose transport and utilization in vitro and in vivo.
CAS:
252935-94-7
Formula:
C20H17Cl2N9O2
Molecular Weight:
486.32
Pathway:
Stem Cells; MAPK; Angiogenesis; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors
Purity:
0.9941
SMILES:
Nc1nc(NCCNc2ncc(c(n2)-c2ccc(Cl)cc2Cl)-n2ccnc2)ccc1[N+]([O-])=O
Target:
FGFR; GSK-3; Src; S6 Kinase

References

1. Ring DB,et al. Diabetes. 2003, 52(3), 588-595. 2. Selenica ML, et al. Br J Pharmacol. 2007, 152(6), 959-979.